Group Overview

We have a proud heritage dating back more than 160 years and are committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products.

We are a leading global player in specialty and branded pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to benefit the lives of patients using our products in more than 150 countries.

In line with the our commercial, production and territorial strategies, we have identified Thrombosis, Anaesthetics, High Potency & Cytotoxics and Nutritionals as our focused therapeutic categories that will receive our highest focus based on materiality and future potential.

We operate 25 manufacturing facilities across 17 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies listed here including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines. Our manufacturing capabilities are scaleable to demand and cover a wide variety of product types including oral solid dose, liquids, semi-solids, steriles, biologicals, active pharmaceutical ingredients and nutritionals.